All In Biotech

Free tool

FAERS Monitor: Secuado

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212268 or its brand name (Secuado, Asenapine). Reports on generic versions are filed under their own applications.

Reports

912

Serious

722

79% of reports

Hospitalization

337

Death reported

139

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective115
  • drug interaction87
  • off label use74
  • completed suicide73
  • toxicity to various agents67
  • myocarditis58
  • sedation40
  • depression36
  • somnolence32
  • suicidal ideation32
  • product substitution issue31
  • weight increased31
  • anxiety29
  • hypotension28
  • insomnia28

Reports by year received

View as table
YearReports
201011
201118
201220
201319
201466
201593
201688
201752
201828
201947
202045
202174
2022101
202362
202449
202589
202650

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,247 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myocarditisSignal58117.391.46,542
sedationSignal4035.326.01,298
completed suicideSignal7320.216.21,319
drug interactionSignal8712.710.4929
product substitution issueSignal3112.48.8315
toxicity to various agentsSignal679.27.3483
suicidal ideationSignal328.15.7192
somnolenceSignal323.72.660
depressionSignal363.62.667
hypotensionSignal283.22.241
weight increasedSignal313.22.345
insomniaSignal282.41.722
anxietySignal292.41.621
drug ineffectiveSignal1152.01.761
off label use741.91.635

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.